Journal articles

• Zachariah S, Sheldon B, Shojaee-Moradie F, Jackson NC, Backhouse K, Johnsen S, Jones RH, Umpleby AM, Russell-Jones DL. (2011) 'Insulin detemir reduces weight gain as a result of reduced food intake in patients with type 1 diabetes.'. Diabetes Care, United States: 34 (7), pp. 1487-1491.
  doi: 10.2337/dc11-0098
  Full text is available at: http://epubs.surrey.ac.uk/710270/

  Abstract

  Insulin detemir lacks the usual propensity for insulin to cause weight gain. We investigated whether this effect was a result of reduced energy intake and/or increased energy expenditure.

• Whyte MB, Jackson NC, Shojaee-Moradie F, Treacher DF, Beale RJ, Jones RH, Umpleby AM. (2010) 'Metabolic effects of intensive insulin therapy in critically ill patients'. AMER PHYSIOLOGICAL SOC AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 298 (3), pp. E697-E705.
  doi: 10.1152/ajpendo.00407.2009
• Brackenridge AL, Jackson N, Jefferson W, Stolinski M, Shojaee-Moradie F, Hovorka R, Umpleby AM, Russell-Jones D. (2009) 'Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids'. WILEY-BLACKWELL PUBLISHING, INC DIABETIC MEDICINE, 26 (5), pp. 532-539.
  doi: 10.1111/j.1464-5491.2009.02729.x
  Full text is available at: http://epubs.surrey.ac.uk/711084/
• Stolinski M, Alam S, Jackson NC, Shojaee-Moradie F, Pentecost C, Jefferson W, Christ ER, Jones RH, Umpleby AM. (2008) 'Effect of 6-month supervised exercise on low-density lipoprotein apolipoprotein B kinetics in patients with type 2 diabetes mellitus'. W B SAUNDERS CO-ELSEVIER INC METABOLISM-CLINICAL AND EXPERIMENTAL, 57 (11), pp. 1608-1614.
  doi: 10.1016/j.metabol.2008.06.018
• Giannoulis MG, Jackson N, Shojaee-Moradie F, Nair KS, Sonksen PH, Martin FC, Umpleby AM. (2008) 'The effects of growth hormone and/or testosterone on whole body protein kinetics and skeletal muscle gene expression in healthy elderly men: A randomized controlled trial'. ENDOCRINE SOC JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 93 (8), pp. 3066-3074.
  doi: 10.1210/jc.2007-2695
  Full text is available at: http://epubs.surrey.ac.uk/1671/
• Shojaee-Moradie F, Baynes KCR, Pentecost C, Bell JD, Thomas EL, Jackson NC, Stolinski M, Whyte M, Lovell D, Bowes SB, Gibney J, Jones RH, Umpleby AM. (2007) 'Exercise training reduces fatty acid availability and improves the insulin sensitivity of glucose metabolism'. SPRINGER DIABETOLOGIA, 50 (2), pp. 404-413.
  doi: 10.1007/s00125-006-0498-7
• Giannoulis MG, Jackson N, Shojaee-Moradie F, Sonksen PH, Martin FC, Umpleby AM. (2006) 'Effects of growth hormone and/or testosterone on very low density lipoprotein apolipoprotein B100 kinetics and plasma lipids in healthy elderly men: A randomised controlled trial'. CHURCHILL LIVINGSTONE GROWTH HORMONE & IGF RESEARCH, 16 (5-6), pp. 308-317.
  doi: 10.1016/j.ghir.2006.08.001
• Wee J, Charlton C, Simpson H, Jackson NC, Shojaee-Moradie F, Stolinski M, Pentecost C, Umpleby AM. (2005) 'GH secretion in acute exercise may result in post-exercise lipolysis.'. Growth Horm IGF Res, Scotland: 15 (6), pp. 397-404.
  doi: 10.1016/j.ghir.2005.08.003
• Umpleby AM, Das S, Stolinski M, Shojaee-Moradie F, Jackson NC, Jefferson W, Crabtree N, Nightingale P, Shahmanesh M. (2005) 'Low density lipoprotein apolipoprotein B metabolism in treatment-naive HIV patients and patients on antiretroviral therapy.'. Antivir Ther, England: 10 (5), pp. 663-670.
• Carroll PV, Jackson NC, Russell-Jones DL, Treacher DF, Sönksen PH, Umpleby AM. (2004) 'Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness.'. Am J Physiol Endocrinol Metab, United States: 286 (1), pp. E151-E157.
  doi: 10.1152/ajpendo.00122.2003
• Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sönksen PH, Dunger DB, Umpleby AM. (2004) 'Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes.'. J Clin Endocrinol Metab, United States: 89 (1), pp. 425-432.
• Hovorka R, Shojaee-Moradie F, Carroll PV, Chassin LJ, Gowrie IJ, Jackson NC, Tudor RS, Umpleby AM, Jones RH. (2002) 'Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT.'. Am J Physiol Endocrinol Metab, United States: 282 (5), pp. E992-1007.
  doi: 10.1152/ajpendo.00304.2001
• Umpleby AM, Carroll PV, Russell-Jones DL, Treacher DF, Jackson NC. (2002) 'Glutamine supplementation and GH/IGF-I treatment in critically ill patients: effects on glutamine metabolism and protein balance.'. Nutrition, United States: 18 (2), pp. 127-129.
• Carroll PV, Christ ER, Umpleby AM, Gowrie I, Jackson N, Bowes SB, Hovorka R, Croos P, Sönksen PH, Russell-Jones DL. (2000) 'IGF-I treatment in adults with type 1 diabetes: effects on glucose and protein metabolism in the fasting state and during a hyperinsulinemic-euglycemic amino acid clamp.'. Diabetes, UNITED STATES: 49 (5), pp. 789-796.
• Jackson NC, Carroll PV, Russell-Jones DL, Sönksen PH, Treacher DF, Umpleby AM. (2000) 'Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patients.'. Am J Physiol Endocrinol Metab, UNITED STATES: 278 (2), pp. E226-E233.
• Hovorka R, Carroll PV, Gowrie IJ, Jackson NC, Russell-Jones DL, Umpleby AM. (1999) 'A surrogate measure of whole body leucine transport across the cell membrane.'. Am J Physiol, UNITED STATES: 276 (3 Pt 1), pp. E573-E579.
• Jackson NC, Carroll PV, Russell-Jones DL, Sönksen PH, Treacher DF, Umpleby AM. (1999) 'The metabolic consequences of critical illness: acute effects on glutamine and protein metabolism.'. Am J Physiol, UNITED STATES: 276 (1 Pt 1), pp. E163-E170.
• Shojaee-Moradie F, Eckey H, Jackson NC, Schüttler A, Brandenburg D, Sönksen PH, Jones RH. (1998) 'Novel hepatoselective insulin analogues: studies with covalently linked thyroxyl-insulin complexes.'. Diabet Med, ENGLAND: 15 (11), pp. 928-936.
  doi: 10.1002/(SICI)1096-9136(1998110)15:11<928::AID-DIA702>3.0.CO;2-W
• Russell-Jones DL, Bowes SB, Rees SE, Jackson NC, Weissberger AJ, Hovorka R, Sonksen PH, Umpleby AM. (1998) 'Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults.'. Am J Physiol, UNITED STATES: 274 (6 Pt 1), pp. E1050-E1056.
• Carroll PV, Umpleby AM, Albany E, Jackson NC, Morgan-Hughes JA, Sonksen PH, Russell-Jones DL. (1997) 'Growth hormone therapy may benefit protein metabolism in mitochondrial encephalomyopathy.'. Clin Endocrinol (Oxf), ENGLAND: 47 (1), pp. 113-117.
• Bowes SB, Umpleby M, Cummings MH, Jackson NC, Carroll PV, Lowy C, Sönksen PH, Russell-Jones DL. (1997) 'The effect of recombinant human growth hormone on glucose and leucine metabolism in Cushing's syndrome.'. J Clin Endocrinol Metab, UNITED STATES: 82 (1), pp. 243-246.
• Shojaee-Moradie F, Jackson NC, Jones RH, Mallet AI, Hovorka R, Umpleby AM. (1996) 'Quantitative measurement of 3-O-methyl-D-glucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivo.'. J Mass Spectrom, ENGLAND: 31 (9), pp. 961-966.
  doi: 10.1002/(SICI)1096-9888(199609)31:9<961::AID-JMS359>3.0.CO;2-H
• Bowes SB, Hennessy TR, Umpleby AM, Benn JJ, Jackson NC, Boroujerdi MA, Sönksen PH, Lowy C. (1996) 'Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes.'. Diabetologia, GERMANY: 39 (8), pp. 976-983.
• Bowes SB, Jackson NC, Papachristodoulou D, Umpleby AM, Sönksen PH. (1996) 'Effect of corticosterone on protein degradation in isolated rat soleus and extensor digitorum longus muscles.'. J Endocrinol, ENGLAND: 148 (3), pp. 501-507.
• Shojaee-Moradie F, Umpleby AM, Thomason MJ, Jackson NC, Boroujerdi MA, Sönksen PH, Skottner A, Jones RH. (1995) 'A comparison of the effects of insulin-like growth factor-I, insulin and combined infusions of insulin and insulin-like growth factor-I on glucose metabolism in dogs.'. Eur J Clin Invest, ENGLAND: 25 (12), pp. 920-928.
• Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Kelly JM, Jackson NC, Sönksen PH. (1995) 'Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.'. Diabetes, UNITED STATES: 44 (9), pp. 1059-1065.
• Russell-Jones DL, Bates AT, Umpleby AM, Hennessy TR, Bowes SB, Hopkins KD, Jackson N, Kelly J, Shojaee-Moradie F, Jones RH. (1995) 'A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers.'. Eur J Clin Invest, ENGLAND: 25 (6), pp. 403-411.
• Russell-Jones DL, Umpleby AM, Hennessy TR, Bowes SB, Shojaee-Moradie F, Hopkins KD, Jackson NC, Kelly JM, Jones RH, Sönksen PH. (1994) 'Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans.'. Am J Physiol, UNITED STATES: 267 (4 Pt 1), pp. E591-E598.